$396 Million is the total value of Vida Ventures Advisors, LLC's 8 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRAX | Praxis Precision Medicines, Inc. | $96,292,000 | -40.5% | 2,939,329 | 0.0% | 24.33% | -26.7% | |
| KNTE | Buy | Kinnate Biopharma, Inc. | $85,610,000 | -21.7% | 2,747,433 | +0.0% | 21.63% | -3.6% |
| KRON | Kronos Bio, Inc. | $80,941,000 | -2.0% | 2,765,314 | 0.0% | 20.45% | +20.6% | |
| ALLO | Allogene Therapeutics, Inc. | $63,475,000 | +39.9% | 1,798,163 | 0.0% | 16.04% | +72.1% | |
| DYN | Dyne Therapeutics, Inc. | $45,970,000 | -26.0% | 2,960,046 | 0.0% | 11.61% | -9.0% | |
| OYST | Oyster Point Pharma, Inc. | $14,230,000 | -2.9% | 778,468 | 0.0% | 3.60% | +19.6% | |
| FIXX | Homology Medicines, Inc. | $7,254,000 | -16.6% | 770,845 | 0.0% | 1.83% | +2.6% | |
| ASMB | Assembly Biosciences, Inc. | $2,070,000 | -24.0% | 450,000 | 0.0% | 0.52% | -6.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Dyne Therapeutics, Inc. | 14 | Q4 2023 | 37.4% |
| Allogene Therapeutics, Inc. | 14 | Q4 2023 | 42.5% |
| Kinnate Biopharma, Inc. | 13 | Q4 2023 | 29.3% |
| Kronos Bio, Inc. | 13 | Q4 2023 | 20.4% |
| Praxis Precision Medicines, Inc. | 12 | Q3 2023 | 33.2% |
| Centessa Pharmaceuticals plc | 11 | Q4 2023 | 39.4% |
| LianBio | 9 | Q4 2023 | 12.1% |
| Homology Medicines, Inc. | 9 | Q3 2022 | 5.2% |
| Oyster Pt Pharma Inc | 5 | Q3 2021 | 10.3% |
| Assembly Biosciences, Inc. | 4 | Q2 2021 | 4.6% |
View Vida Ventures Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-12 |
| 13F-HR | 2024-01-05 |
| 13F-HR | 2023-10-03 |
| 13F-HR | 2023-07-19 |
| 13F-HR | 2023-04-13 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-10-05 |
| 13F-HR | 2022-07-15 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-10 |
View Vida Ventures Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.